Blinatumomab is associated with favorable outcomes in patients with B‐cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10 −4 and higher

Autor: Elias J. Jabbour, Nicholas J. Short, Nitin Jain, Nadya Jammal, Jeffrey Jorgensen, Sa Wang, Xuemei Wang, Maro Ohanian, Yesid Alvarado, Tapan Kadia, Koji Sasaki, Rebecca Garris, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian
Rok vydání: 2022
Předmět:
Zdroj: American Journal of Hematology. 97:1135-1141
ISSN: 1096-8652
0361-8609
DOI: 10.1002/ajh.26634
Databáze: OpenAIRE
Externí odkaz: